Empiric antibiotic selection strategies for healthcare‐associated pneumonia, intra‐abdominal infections, and catheter‐associated bacteremia
- 3 January 2012
- journal article
- review article
- Published by Wiley in Journal of Hospital Medicine
- Vol. 7 (S1) , S2-S12
Abstract
Initial selection and early deployment of appropriate/adequate empiric antimicrobial therapy is critical to minimize the significant morbidity and mortality associated with hospital‐ or healthcare‐associated infections (HAIs). Initial empiric therapy that inadequately covers the pathogen(s) causing a serious HAI has been associated with increased mortality, longer hospital stay, and elevated healthcare costs. Moreover, subsequent modification of initial inadequate therapy, later in the disease process when culture results become available, may not remedy the impact of the initial choice. Because of this, it is important that initial empiric therapy covers the most likely pathogens associated with infection in a particular patient, even if this initial regimen turns out to be unnecessarily broad, based on subsequent culture results. The current paradigm for management of serious HAIs is to initiate empiric therapy with a broad‐spectrum regimen covering likely pathogens, based on local surveillance and susceptibility data, and presence of risk factors for involvement of a resistant microorganism. Subsequent modification (de‐escalation) of the initial regimen becomes possible later, when culture results are available and clinical status can be better assessed, 2 to 4 days after initiation of empiric therapy. When possible, de‐escalation and other steps to modify antimicrobial exposure are important for minimizing risk of antimicrobial resistance development. This article examines the general process for selection of initial empiric antibiotic therapy for patients with HAIs, illustrated through 3 case studies dealing with healthcare‐associated pneumonia, complicated intra‐abdominal infection, and catheter‐associated bacteremia, respectively. Journal of Hospital Medicine 2012;7:S2–S12. © 2012 Society of Hospital MedicineKeywords
This publication has 92 references indexed in Scilit:
- Impact of Multidrug-Resistant Pseudomonas aeruginosa Bacteremia on Patient OutcomesAntimicrobial Agents and Chemotherapy, 2010
- Susceptibility of Gram-Negative Pathogens Isolated from Patients with Complicated Intra-Abdominal Infections in the United States, 2007-2008: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)Antimicrobial Agents and Chemotherapy, 2010
- The Value of Infectious Diseases Consultation in Staphylococcus aureus BacteremiaThe American Journal of Medicine, 2010
- A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for preventionIndian Journal of Anaesthesia, 2010
- Infectious Diseases Consultation Lowers Mortality From Staphylococcus aureus BacteremiaMedicine, 2009
- Pharmacokinetic and Pharmacodynamic Parameters of AntimicrobialsClinical Pharmacokinetics, 2009
- Morbidity associated with Pseudomonas aeruginosa bloodstream infectionsDiagnostic Microbiology and Infectious Disease, 2009
- Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007Journal of Antimicrobial Chemotherapy, 2009
- Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative BacilliAntimicrobial Agents and Chemotherapy, 2008
- Blood Culture Contamination in Tanzania, Malawi, and the United States: a Microbiological Tale of Three CitiesJournal of Clinical Microbiology, 2006